NCT02164253View on ClinicalTrials.gov

Focal Accumulation of Iron in Cerebral Regions in Early ALS (Amyotrophic Lateral Sclerosis) Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
ALS (Amyotrophic Lateral Sclerosis)Iron Overload
Interventions
DRUG

Deferiprone

30 mg/kg per day, oral use

Trial Locations (1)

59000

Hôpital Roger Salengro, CHRU de Lille, Lille

Sponsors

Collaborators (1)

ApoPharma
All Listed Sponsors
collaborator

ApoPharma

INDUSTRY

lead

University Hospital, Lille

OTHER

NCT02164253 - Focal Accumulation of Iron in Cerebral Regions in Early ALS (Amyotrophic Lateral Sclerosis) Patients | Biotech Hunter | Biotech Hunter